Found 21 matching trials
Patient Preference for Pegfilgrastim (Neulasta®) Application Forms
NAThe study aims to compare two application forms (pre-filled syringe and On-...
Sorrel 25R Injector - Sorrel Clinical Study Protocol
NAA prospective, open-label, single-center pilot study to evaluate the perfor...
Location
Thomas Jefferson University Hospital
Prevalence of Occult Hepatitis B Virus Infection(OBI) in Subjects With Chronic Hepatitis B(CHB) Family History
N/AMother to Child transmission is the main route of hepatitis B virus (HBV) t...
Location
First Affiliated Hospital of Xi'an JiaotongUniversity
Combination SBRT With TACE for Unresectable Hepatocellular Carcinoma
PHASE1To determine the efficacy and toxicity of TACE combined with SBRT...
Location
Stanford University School of Medicine
Pharmacokinetic Comparability Study in Healthy Participants - PF-06881894 On-Body Injector Relative to Prefilled Syringe
PHASE1This will be an open-label, randomized, 2-treatment, 2-period, crossover si...
Location
Anaheim Clinical Trials, LLC
LCL161 Plus Topotecan for Patients With Relapsed/Refractory Small Cell Lung Cancer and Select Gynecologic Malignancies
PHASE1This trial will investigate the combination of two anti-cancer agents to tr...
Location
Florida Cancer Specialists-Sarasota
Menopausal Symptoms and Burnout: Comparison of Occupational Health Issue Among Health Professionals in UMC Hospitals
N/AThis study aims at evaluating the burnout in women healthcare providers (ph...
Location
Multiple Locations
Setup Variation in the Supraclavicular Lymph Nodes Treatment in Breast Cancer Patients
N/AThe goal of this clinical research study is to use the On Board Imager kilo...
Location
University of Texas MD Anderson Cancer Center
Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)
PHASE1This phase I/II trial studies the safety, side effects and best dose of OBI...
Location
University of Alabama at Birmingham Cancer Center
A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease
PHASE3The study consists of 4 sub-studies, as follows:
* Sub-study 1 (Randomized...
Status
Active Not Recruiting
Location
Digestive Disease Consultants, A Division of Arizona Digestive Health, P.C /ID# 211884